SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 27.06 million declined by -99.00% from Rs. 2703.00 millions.A big loss of -98.94% reported for the quarter ended September 2024 to Rs. 3.20  millions from Rs. 300.95 millions.A decline of 9.47 millions was observed in the OP in the quarter ended September 2024 from 707.96 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 27.06 2703.00 -99.00 331.62 5693.06 -94.18 12273.18 11519.57 6.54
Other Income 129.46 73.97 75.02 240.85 129.50 85.98 453.14 332.82 36.15
PBIDT 9.47 707.96 -98.66 75.54 1361.63 -94.45 2952.81 2553.74 15.63
Interest 4.11 211.38 -98.06 5.80 415.22 -98.60 510.96 921.66 -44.56
PBDT 5.36 496.58 -98.92 69.74 946.41 -92.63 6307.75 1365.60 361.90
Depreciation 2.16 131.88 -98.36 4.66 270.73 -98.28 533.03 573.62 -7.08
PBT 3.20 364.70 -99.12 65.08 675.68 -90.37 5774.72 791.98 629.15
TAX 0.00 63.75 0.00 0.00 204.24 0.00 1590.81 367.25 333.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -108.43 233.61 -146.41
PAT 3.20 300.95 -98.94 65.08 471.44 -86.20 4183.91 424.73 885.08
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 35.00 26.19 33.62 22.78 23.92 -4.76 24.06 22.17 8.53

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×